[Other] [MinervaMedica] Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation |
|
This post will be closed automatically in 2026-06-26 20:28
Reward45points
|
post
reply
points
187108
30
Medical Management of Type 2 Diabetes
300
[Full book]2025 ASHRAE Handbook—Fundamentals
20
Dyes for guest–host liquid crystal applications: a general approach to the rapid computational assessment of useful molecular designs
50
[Full book]Data Governance. From the Fundamentals to Real Cases
50
[Full book]Revolutionary Impact of 5G on Advancement of Technology in Healthcare
